Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$710,370
+$446,180 QoQ
Shares Held
147,994
+152.1% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ABUS ranks #156 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ABUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $710,370 | 147,994 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $264,190 | 58,709 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $803,371 | 167,021 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $433,347 | 95,451 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $248,646 | 80,468 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $251,855 | 72,165 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $230,858 | 70,599 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $187,999 | 48,831 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $148,743 | 48,137 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $110,656 | 42,890 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $93,915 | 37,566 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $65,179 | 32,108 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $127,045 | 55,237 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $84,403 | 27,856 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $21,205 | 9,101 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,130 | 7,922 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,652 | 7,621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $282,521 | 94,806 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $457,817 | 117,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,820,769 | 424,422 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,895 | 3,926 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,570 | 4,676 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $16,727 | 4,712 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $16,700 | 5,336 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,278 | 2,900 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,929 | 2,900 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||